Clinical and Peripheral Blood Markers Predict Relapsed/Refractory Multiple Myeloma Prior to Autologous Stem Cell Transplant. GMSJ. 2025;1(S1). Accessed August 24, 2026. http://gmscholars.com/index.php/gmsj/article/view/59